Tirzepatide 10 mg | Dual GIP & GLP-1 Receptor Agonist | Research Compound

Tirzepatide is a peptide compound with dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual-receptor mechanism has made it an extensively studied compound in metabolic and endocrine research.

Research involving tirzepatide has examined pathways associated with glucose regulation, insulin signaling, energy metabolism, appetite signaling, and metabolic function. Its ability to interact with two distinct incretin receptor systems makes it particularly useful for research investigating the complex relationship between cellular signaling and metabolic processes.

Each Zevoryn Labs vial contains 10 mg of lyophilized Tirzepatide, packaged for controlled laboratory and analytical research applications.

Product Specifications: Tirzepatide | 10 mg per vial | Lyophilized peptide | Laboratory research application

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, DIAGNOSTIC USE, OR THERAPEUTIC USE.